PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BMY vs. SCHD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Performance

BMY vs. SCHD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bristol-Myers Squibb Company (BMY) and Schwab US Dividend Equity ETF (SCHD). The values are adjusted to include any dividend payments, if applicable.

100.00%200.00%300.00%400.00%JuneJulyAugustSeptemberOctoberNovember
174.33%
427.25%
BMY
SCHD

Returns By Period

In the year-to-date period, BMY achieves a 20.54% return, which is significantly higher than SCHD's 18.85% return. Over the past 10 years, BMY has underperformed SCHD with an annualized return of 3.17%, while SCHD has yielded a comparatively higher 11.69% annualized return.


BMY

YTD

20.54%

1M

11.24%

6M

46.54%

1Y

24.29%

5Y (annualized)

4.58%

10Y (annualized)

3.17%

SCHD

YTD

18.85%

1M

3.78%

6M

14.95%

1Y

27.79%

5Y (annualized)

13.14%

10Y (annualized)

11.69%

Key characteristics


BMYSCHD
Sharpe Ratio0.892.49
Sortino Ratio1.563.58
Omega Ratio1.191.44
Calmar Ratio0.533.79
Martin Ratio2.1813.58
Ulcer Index11.51%2.05%
Daily Std Dev28.37%11.15%
Max Drawdown-70.62%-33.37%
Current Drawdown-21.05%0.00%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.5

The correlation between BMY and SCHD is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Risk-Adjusted Performance

BMY vs. SCHD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and Schwab US Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BMY, currently valued at 0.89, compared to the broader market-4.00-2.000.002.004.000.892.49
The chart of Sortino ratio for BMY, currently valued at 1.56, compared to the broader market-4.00-2.000.002.004.001.563.58
The chart of Omega ratio for BMY, currently valued at 1.19, compared to the broader market0.501.001.502.001.191.44
The chart of Calmar ratio for BMY, currently valued at 0.53, compared to the broader market0.002.004.006.000.533.79
The chart of Martin ratio for BMY, currently valued at 2.18, compared to the broader market0.0010.0020.0030.002.1813.58
BMY
SCHD

The current BMY Sharpe Ratio is 0.89, which is lower than the SCHD Sharpe Ratio of 2.49. The chart below compares the historical Sharpe Ratios of BMY and SCHD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
0.89
2.49
BMY
SCHD

Dividends

BMY vs. SCHD - Dividend Comparison

BMY's dividend yield for the trailing twelve months is around 4.08%, more than SCHD's 3.33% yield.


TTM20232022202120202019201820172016201520142013
BMY
Bristol-Myers Squibb Company
4.08%4.44%3.00%2.36%3.69%2.55%3.08%2.55%1.95%2.17%2.46%3.31%
SCHD
Schwab US Dividend Equity ETF
3.33%3.49%3.39%2.78%3.16%2.98%3.06%2.63%2.89%2.97%2.63%2.47%

Drawdowns

BMY vs. SCHD - Drawdown Comparison

The maximum BMY drawdown since its inception was -70.62%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for BMY and SCHD. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-21.05%
0
BMY
SCHD

Volatility

BMY vs. SCHD - Volatility Comparison

Bristol-Myers Squibb Company (BMY) has a higher volatility of 13.60% compared to Schwab US Dividend Equity ETF (SCHD) at 3.67%. This indicates that BMY's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%JuneJulyAugustSeptemberOctoberNovember
13.60%
3.67%
BMY
SCHD